4D Molecular Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
4D Molecular Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • 4D Molecular Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $1.2M, a 9.09% increase year-over-year.
  • 4D Molecular Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $4.8M, a 14.3% increase year-over-year.
  • 4D Molecular Therapeutics, Inc. annual Depreciation for 2023 was $4.4M, a 83.3% increase from 2022.
  • 4D Molecular Therapeutics, Inc. annual Depreciation for 2022 was $2.4M, a 60% increase from 2021.
  • 4D Molecular Therapeutics, Inc. annual Depreciation for 2021 was $1.5M, a 7.14% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.4M +$2M +83.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $2.4M +$900K +60% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $1.5M +$100K +7.14% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $1.4M +$400K +40% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $1M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.